Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease

Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Behçet Behcet Syndrome Cardiovascular Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Eye Diseases Genetic Diseases, Inborn Hereditary Autoinflammatory Diseases Mouth Diseases Panuveitis Skin Diseases Skin Diseases, Genetic Skin Diseases, Vascular Skin and Connective Tissue Diseases Stomatognathic Diseases Uveal Diseases Uveitis Uveitis, Anterior Vascular Diseases Vasculitis

Age range

19 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag university

Sohag, Egypt

Location status: Recruiting

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients fulfill the International Criteria for Behcet's Disease (ICBD)
Age above 18 years old
Patients cooperative and can answer questions
Patients who are able and willing to give informed consent

Exclusion criteria

Other rheumatological and vascular diseases
Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
Patients who are using aspirin and other platelet active drygs during the previous 6 months
patients who are not able and willing to give written consent

Treatment and study plan

Primary outcomes

Femoral Vein Wall thickness

Time frame: One week

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Dec 6, 2024
Registry last updated: Dec 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed